News Posts List
Moye Rules Video Challenge
03/01/2010
Wideout crowned team champion in Xbox tourney as Nittany Lions look to call attention to Global Rare Disease Day. The action included a stunning upset in the first round.
3rd Annual Kidney Cancer Symposium
03/01/2010
A phase II clinical trial of ixabepilone , an epothilone B analog, in patients with metastatic renal cell carcinoma
02/28/2010
This phase II study was conducted to assess the efficacy and safety of ixabepilone in patients with metastatic renal cell carcinoma. Ixabepilone can cause tumor regression in some patients with metastatic renal cell carcinoma and could be considered in combination regimens with other therapies.
Sorafenib-associated remission of psoriasis in hypernephroma: Case report
02/28/2010
Psoriasis is thought to be angiogenesis dependent. Clear cell renal cell carcinoma is a hypervascularized solid tumor associated with loss of function of the von Hippel_Lindau (VHL) tumor suppressor.
Recent updates in renal cell carcinoma
02/28/2010
The field of RCC biology continues to rapidly change. As new targeted strategies to control this cancer evolve, so do both the clinical strategies, and the strategies to measure response and predict outcome.
How Kidney Cancer Research Benefits From The American Recovery and Reinvestment Act of 2009
02/27/2010
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: Comparison with the Memorial Sloan-Kettering prognostic factors model
02/27/2010
The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the established Memorial Sloan Kettering Cancer Center (MSKCC) model. Studies on risk stratification of patients with advanced RCC treated with targeted therapies are warranted. Our results suggest that a simpler than the MSKCC model can be developed.
Researchers from Yamagata University, Department of Urology detail findings in renal cell carcinoma
02/27/2010
Data detailed in 'Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients' have been presented. According to recent research from Yamagata, Japan, "Incidence rate of renal cell carcinoma (RCC) differs among countries. The rates of Asian countries are lower than those of countries in North America or Europe but are exceptionally high in Japanese males."
Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma - Abstract
02/27/2010
Low serum sodium has recently been associated with poor survival in localised renal cell carcinoma (RCC). We now show the prognostic effect of serum sodium in patients with metastatic RCC (mRCC).
News Feed